Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Sales5886848841 0461 1531 266
Operating income (EBITDA)136161231286323362
Operating profit (EBIT)-120-242274308
Pre-Tax Profit (EBT)-105170230264298
Net income67,572,5139163188212
P/E ratio24,934,239,037,933,227,7
EPS ( € )0,820,791,511,681,922,29
Dividend per Share ( € )0,200,22-0,370,420,53
Yield0,98%0,81%-0,58%0,65%0,83%
Reference price ( € )20.308326.883358.963.6363.6363.63
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201320142015201620172018
Debt-87,486,477,726,4-
Finance-----138
Operating income (EBITDA)136161231286323362
Leverage
(Debt/EBITDA)
-0,54x0,37x0,27x0,08x-
Capital Expenditure29,347,153,072,579,678,6
Book Value Per Share (BVPS)-5,78 €6,96 €8,11 €9,80 €11,8 €
Cash Flow per Share-1,21 €-2,16 €2,51 €2,83 €
Announcement Date01/28/2014
06:00am
01/27/2015
04:00pm
02/01/2016
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 5 865 M€ -
Entreprise Value (EV) 5 943 M€ 5 892 M€
Valuation 2016e 2017e
P/E ratio (Price / EPS) 37,9x 33,2x
Capitalization / Revenue 5,61x 5,08x
EV / Revenue 5,68x 5,11x
EV / EBITDA 20,8x 18,2x
Yield (DPS / Price) 0,58% 0,65%
Price to book (Price / BVPS) 7,84x 6,49x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 23,1% 23,7%
operating Leverage (Delta EBIT / Delta Sales) - 1,30x
Net Margin (Net Profit / Revenue) 15,6% 16,3%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 23,2% 21,9%
Rate of Dividend 22,2% 21,7%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,93% 6,90%
Cash Flow / Sales 19,0% 20,1%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,27x 0,08x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend